Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Influence of genotype on hepatitis B surface antigen kinetics in hepatitis B e antigen-negative patients treated with pegylated interferon-alpha2a.

Antiviral therapy - 1 Jan 2009

Moucari Rami, Martinot-Peignoux Michelle, Mackiewicz Vincent, Boyer Nathalie, Ripault Marie-Pierre, Castelnau Corinne, Leclere Laurence, Dauvergne Agnes, Valla Dominique, Vidaud Michel, Nicolas-Chanoine Marie-Hélène, Marcellin Patrick

Abstract excerpt

BACKGROUND: The aim of this study was to assess the influence of hepatitis B virus (HBV) genotypes on serum hepatitis B surface antigen (HBsAg) kinetics in hepatitis B e antigen (HBeAg)-negative patients treated with pegylated interferon-alpha2a (PEG-IFN-alpha2a). METHODS: A total of 48 consecuti...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antiviral Agents
Share to Hepatitis B, Chronic

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hepatitis B e Antigens

Share to Hepatitis B Surface Antigens

Share to Hepatitis B virus

Share to Interferon-alpha

Share to Interferon alpha-2

Share to Polyethylene Glycols

Source

Identifiers

PMID: 20032548
DOI: 10.3851/IMP1458

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-20032548-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Influence of genotype on hepatitis B surface antigen kinetics in hepatitis B e antigen-negative patients treated with pegylated interferon-alpha2a.PMID 20032548Read ↗

Hepatitis B virus genotypes: an overview.Semantic proximity Read ↗

Genotype impact on long-term virological outcome of chronic hepatitis B virus infection.Semantic proximity Read ↗

Hepatitis B virus genotypes: Do they play a role in the outcome of HBV infection?Semantic proximity Read ↗

Response to peginterferon alfa-2a (40KD) in HBeAg-negative CHB: on-treatment kinetics of HBsAg serum levels vary by HBV genotype.Semantic proximity Read ↗

Durable hepatitis B surface antigen decline in hepatitis B e antigen-positive chronic hepatitis B patients treated with pegylated interferon-α2b: relation to response and HBV genotype.Semantic proximity Read ↗

Role of HBsAg decline in patients with chronic hepatitis B HBeAg-negative and E genotype treated with pegylated-interferon.Semantic proximity Read ↗

Do we need to determine viral genotype in treating chronic hepatitis B?Semantic proximity Read ↗

[Influences of the genotypes of HBV and HBeAg regarding their response to PEG-IFN in chronic hepatitis B patients].Semantic proximity Read ↗

The response to interferon is influenced by hepatitis B virus genotype in vitro and in vivo.Semantic proximity Read ↗

The significance of hepatitis B virus (HBV) genotypes for the disease and treatment outcome among patients with chronic hepatitis B in Serbia.Semantic proximity Read ↗

Treatment with Peg-interferon alpha-2b for HBeAg-positive chronic hepatitis B: HBsAg loss is associated with HBV genotype.Semantic proximity Read ↗

Is response to antiviral treatment influenced by hepatitis B virus genotype?Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.